RANDOMIZED PHASE II STUDY OF P62/SQSTM1-ENCODING PLASMID (ELENAGEN) IN COMBINATION WITH GEMCITABINE FOR PLATINUM-RESISTANT OVARIAN CANCER

International Journal of Gynecological Cancer 2026

View at publisher
Authors: Sergei A. Krasny, Yauheni Valerievich Baranau, Eugene Bakin, S. Polyakov, Olga Streltsova, Ekaterina Zharkova, Aliona Filimonava, Gabriel Levin, Vladimir L. Gabai, Alexander M. Shneider
DOI: 10.1016/j.ijgc.2025.104424
Cited by: 1

Fields of Study & Subjects

PARP inhibition in cancer therapy Cancer-related Molecular Pathways Microtubule and mitosis dynamics

Publication details

Journal / source
International Journal of Gynecological Cancer
Publisher
Elsevier BV
Volume
36
Issue
2
Pages
104424–104424
Publication date
1 February 2026
Language
EN